Table 2.
Brain-derived neurotropic factor rs6265 genotype distributions among T2DM cases and controls of the included studies.
| Cases | Controls | ||||||||
| First author | Year | GG | GA | AA | GG | GA | AA | MAF | P (HWE)∗ |
| Chen Y[12] | 2019 | 172 | 213 | 33 | 176 | 202 | 44 | 34.4 | .209 |
| Zhen YF[13] | 2018 | 76 | 165 | 70 | 88 | 183 | 75 | 48.1 | .27 |
| Jin Y[14] | 2015 | 16 | 19 | 37 | 127 | 45 | 36 | 28.1 | <.001 |
| Xu HY[15] | 2014 | 53 | 68 | 39 | 30 | 35 | 15 | 40.6 | .405 |
| Zhou JX[16] | 2014 | 26 | 33 | 11 | 103 | 137 | 56 | 42.1 | .386 |
| Cao Y[17] | 2011 | 106 | 179 | 73 | 24 | 98 | 64 | 60.8 | .153 |
| Zhou DH[18] | 2010 | 22 | 44 | 25 | 59 | 82 | 50 | 47.6 | .054 |
| Krabbe KS[19] | 2007 | 61 | 30 | 5 | 88 | 42 | 7 | 20.4 | .502 |
HWE = Hardy-Weinberg equilibrium, MAF = minor allele frequency.
P value of chi-square test for HWE among controls.